Short communicationPublished 28 Aug 2021
Stability, activation and antymycobacterial activity of pyrazinoic acid esters
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tuberculosis is a leading infectious cause of morbility and mortality world-wide, especially in developing countries Pyrazinamide (PZA), a first line agent for the treatment of tuberculosis, is itself a prodrug that requires activation by the bacterial pyrazinamidase to form its active metabolite pyrazinoic acid (POA) 2, which has poor absorption and significant serum binding. Resistance to PZA is attributed to mutations in the mycobacterial gene encoding pyrazinamidase. Since PZA is in fact a prodrug of POA, other prodrugs, like esters 3, could have activity against M. tuberculosis.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Research and Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Constantino. L”
